loadpatents
Patent applications and USPTO patent grants for Wang; Ying-Jan.The latest application filed is for "method of identifying a candidate compound which may inhibit a9-nachr overexpression or estrogen receptor-dependent transcription in nicotine-derived-compound-induced breast cancer cells".
Patent | Date |
---|---|
Method of identifying a candidate compound which may inhibit .alpha.9-nAchR overexpression or estrogen receptor-dependent transcription in nicotine-derived-compound-induced breast cancer cells Grant 8,980,571 - Lee , et al. March 17, 2 | 2015-03-17 |
Small interfering RNAs and methods for prevention, inhibition and/or treatment of malignant progression of breast cancer Grant 8,361,984 - Lee , et al. January 29, 2 | 2013-01-29 |
METHOD OF IDENTIFYING A CANDIDATE COMPOUND WHICH MAY INHIBIT a9-nAchR OVEREXPRESSION OR ESTROGEN RECEPTOR-DEPENDENT TRANSCRIPTION IN NICOTINE-DERIVED-COMPOUND-INDUCED BREAST CANCER CELLS App 20120270799 - Lee; Chia-Hwa ;   et al. | 2012-10-25 |
Small Interfering Rnas And Methods For Prevention, Inhibition And/or Treatment Of Malignant Progression Of Breast Cancer App 20120207817 - Lee; Chia-Hwa ;   et al. | 2012-08-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.